Ginko bioworks stock.
The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the last day by ...
Mar 1, 2023 · Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ... Company profile page for Ginkgo Bioworks Inc including stock price, company news, press releases, executives, board members, and contact information Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial ... Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25. The ...
November 6, 2023 at 8:50 AM · 4 min read. We expect investors to focus on the sales performance of Ginkgo Bioworks Holdings, Inc. ’s DNA two business units when the company reports third ...Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help you in your trading and investing decisions. Future criteria checks 2/6. Ginkgo Bioworks Holdings is forecast to grow earnings and revenue by 48.1% and 23.5% per annum respectively. EPS is expected to grow by 48.5% per annum. Return on equity is forecast to be -86.5% in 3 years.
Here’s how four startups are programming biology to develop new products in medicine, energy, food and more. Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help ...Shares of Ginkgo Bioworks ( NYSE: DNA) added ~10% pre-market Tuesday after the cell platform company and Google Cloud, a unit of tech giant Alphabet Inc. ( NASDAQ: GOOG) ( NASDAQ: GOOGL ...
While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections.Ginkgo Bioworks is a story stock with a compelling tale. Ginkgo Bioworks uses DNA to program organic cells to perform a specific function, much like a computer program. Its lab platform, Ginkgo ...Gingko Bioworks shares remain close to their all-time low, but that fact hasn't stopped Cathie Wood and the Ark Invest team from buying more. The flashy ETF firm has added another roughly 25 ...See Ginkgo Bioworks Holdings, Inc. (DNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Ginkgo Bioworks has a fantastic reputation of committing money to R&D. As an investor, I would look past current share pricing and focus on the potential 12-month upside of the company's technology.
Food ingredient company Vivici has partnered with Ginkgo Bioworks to develop a range of new alternative dairy proteins created through precision fermentation, …
7 thg 2, 2022 ... Ginkgo's Platform: A Foundry Tour (Ginkgo Bioworks Investor Day 2021) ... Why We're Avoiding Ginkgo Bioworks Stock $DNA. Nanalyze•12K views · 58 ...
As a member of the SPAC class of 2021, Ginkgo Bioworks ( NYSE: DNA) stock has seen its fair share of pummeling over the last few years. From an all-time high at ~$16 to the stock's current price ...Next-generation biotech Ginkgo Bioworks Holdings ( DNA -3.50%) was one of the star stocks in its sector this week. According to data compiled by S&P Global Market Intelligence, the company's share ...Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the second quarter ended June 30 ...Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ...Ginkgo Bioworks Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. DNA updated stock price target summary.
Detailed statistics for Ginkgo Bioworks Holdings, Inc. (DNA) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. Home. Stocks. ... Ginkgo Bioworks Holdings, Inc. (DNA) NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.46 +0.08 (5.80%) Nov 24, …Nov 18, 2022 · By Chris MacDonald, InvestorPlace Contributor Nov 18, 2022, 1:55 pm EST. Ginkgo Bioworks ( DNA) stock has fallen out of favor in the market. However, Cathie Wood appears to remain very bullish on ... Here’s how four startups are programming biology to develop new products in medicine, energy, food and more. Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help ...Ginkgo Bioworks Holdings, Inc. Warrant (DNA.WS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Ginkgo Bioworks. Market Cap. $3B. Today's Change. (5.80%) $0.08. Current Price. $1.46. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...17 thg 9, 2021 ... Ginkgo's shares opened at $11.15 on the New York Stock Exchange under the ticker symbol “DNA” and closed at $12.18, giving the company a market ...
Nov 18, 2022 · By Chris MacDonald, InvestorPlace Contributor Nov 18, 2022, 1:55 pm EST. Ginkgo Bioworks ( DNA) stock has fallen out of favor in the market. However, Cathie Wood appears to remain very bullish on ... 2 thg 11, 2023 ... Wall Street is positive on Ginkgo Bioworks Holdings Inc (DNA). On average, analysts give DNA a Buy rating. The average price target is ...
Aug 11, 2023 · This week was one to forget for Ginkgo Bioworks ( DNA 5.80%) shareholders. In the Monday-to-Friday period, their investment lost slightly more than 8% of its value on the stock market, according ... The consensus among analysts is that Ginkgo Bioworks Holdings Inc (DNA) is a Hold stock at the moment, with a recommendation rating of 2.67. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 4 out of 9 have rated it as a Hold, with 3 advising it as a Buy. 1 have rated the stock as Underweight.The SRNG-Ginkgo Bioworks merger details. Under the terms of the deal, Ginkgo Bioworks will receive $2.5 billion in gross proceeds to pursue its growth plans. The cash includes $1.7 billion held in ...Ginkgo Bioworks Holdings Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time DNA stock price.Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ...Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 86.67% and 16.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead ...Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ginkgo Bioworks Holdings Inc (NYSE:DNA) Real-Time Quotes. 1.39. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Ginkgo Bioworks Follow Share $0.12 Dec 1, 4:15:01 PM GMT-5 · USD · NYSE · Disclaimer search Compare to In the news The Motley Fool 30 minutes ago If You Invested $1,000 in Ginkgo Bioworks...Jun 7, 2022 · Those are some eye-opening estimates, particularly since the leader in synthetic biomanufacturing, Ginkgo Bioworks (DNA 2.16%), currently has a market cap of $6 billion and trades for a little ...
8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.
Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ...
View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Sep 1, 2023 · Next-generation biotech Ginkgo Bioworks Holdings ( DNA -3.50%) was one of the star stocks in its sector this week. According to data compiled by S&P Global Market Intelligence, the company's share ... The all-stock deal values Zymergen at $300 million market capitalization, a far cry from its roughly $3 billion valuation at its initial public offering last April. Zymergen, which sought to use ...Free Article Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research Wall Street Says Ginkgo Bioworks Stock Will …The company has gotten a lot of attention from Wall Street, but the jury is out on whether Ginkgo can pull off its vision. One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the ...Third quarter 2023 Total revenue of $55 million, down from $66 million in the comparable prior year period, a decrease of 17% primarily driven by the expected ramp down of K-12 testing in Ginkgo's ...Company profile page for Ginkgo Bioworks Inc including stock price, company news, press releases, executives, board members, and contact information The honeymoon for newly minted Ginkgo Bioworks ( DNA 4.11%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ...Ginkgo Bioworks Holdings has a market cap or net worth of $3.03 billion as of December 1, 2023. Its market cap has decreased by -21.13% in one year. Market Cap ... Market Cap = Stock Price * Shares Outstanding. Full Definition. Related Stocks. Company Market Cap; Select Medical Holdings: 2.90B: Organon & Co. 2.89B: Prestige Consumer …First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...Synthetic-biology company Ginkgo Bioworks is getting set to go public by merging with Soaring Eagle Acquisition Corp. ( DNA), a special purpose acquisition …
View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Evgenii Kovalev. Ginkgo Bioworks (NYSE:DNA) is still finding its feet as a public company, with the stock continuing to decline on the back of valuation concerns and declining Biosecurity revenue ...Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help you in your trading and investing decisions. Instagram:https://instagram. companies like robinhoodoxidental stockis humana dental goodqbat With its shares popping by more than 21% in a day in the aftermath of its latest earnings report, Ginkgo Bioworks ( DNA 4.11%) is a hot biotech company that's ripe for investment. After reporting ...“Ginkgo Bioworks does not deserve to use the DNA ticker,” said Stat stock reporter Adam Feuerstein. SPACs are a Wall Street trend that offers an IPO path with a little less than the usual ... freelance tax softwarenlystock The consensus among analysts is that Ginkgo Bioworks Holdings Inc (DNA) is a Hold stock at the moment, with a recommendation rating of 2.67. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 4 out of 9 have rated it as a Hold, with 3 advising it as a Buy. 1 have rated the stock as Underweight. value of 1964 nickel Ginkgo Bioworks originally told investors to expect full-year 2022 revenue of at least $160 million from the biosecurity unit. ... Want TheStreet’s best daily stock and investing news right in ...Not a stock for the Oracle of Omaha (yet) For the uninitiated, Ginkgo Bioworks is a deeply innovative biotech that specializes in automating the design and cultivation of synthetic bacteria and fungi.